ATP13A2 and colonic neoplasm: Expectedly, the Transwell assay showed that decreased ATP13A2 level significantly impaired the mobility of colon cancer cells (Fig. 4a), while elevated ATP13A2 levels markedly enhanced their mobility (Fig. 4b).